Receive news by e-mail

#
 

Enter your e-mail in the field below to receive directly the news that appears on this page.

 

topics : related - all Explore

Shopping Categories

  1. 1. Cell Phones
  2. 2. Smartphones
  3. 3. Digital Cameras
  4. 4. Laptop Computers
  5. 5. Processors
  6. 6. Motherboards
  7. 7. LCD Monitors
  8. 8. Graphics Cards
  9. 9. GPS
  10. 10. Digital Camcorders
  11. 11. Printers
  12. 12. Desktop Computers
  13. 13. Sedans
  14. 14. Coupes & Convertibles
  15. 15. 4x4

Wikio Shopping

  1. 1. Automotive
  2. 2. Beauty & Fragrances
  3. 3. Books
  4. 4. Car/Motorbike
  5. 5. CD
  6. 6. Clothing, Accessories & Shoes
  7. 7. Communication
  8. 8. Computers
  9. 9. DVD
  10. 10. Electronics
  11. 11. Flowers & Gifts
  12. 12. Gourmet & Foods
  13. 13. Health & Personal Care
  14. 14. Home & Garden
  15. 15. Hotels
  16. 16. Household Appliances
  17. 17. Jewelry & Watches
  18. 18. Musical Instruments
  19. 19. Sports & Outdoors
  20. 20. Toys & Baby
  21. 21. Video Games

Participate



Pfizer Inc.



Sort by : relevance - date - popularity
3Vote!

FDA Advisory Committee Finds Data Support The Safety And Effectiveness Of Prevnar 13™ Vaccine For The Prevention Of Invasive Pneumococcal Diseas

Pfizer Inc (NYSE:PFE) announced today that the U.S.

4Vote!

FDA Advisory Committee Finds Data Support the Safety and Effectiveness of Prevnar 13™ Vaccine for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children

NEW YORK--(BUSINESS WIRE)--Pfizer Inc (NYSE:PFE) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee voted 10 to 1 that the data presented support the safety and effectiveness of its 13-valent pneumococcal conjugate candidate vaccine, Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]),...

  • 0 add comment
  • share
3Vote!

Pfizer Submits New Pediatric Data For Lipitor(R) (Atorvastatin) To The European Medicines Agency (EMEA)

Pfizer Inc (NYSE:PFE) announced it has submitted pediatric data for Lipitor® (atorvastatin) to the European Medicines Agency (EMEA). Pfizer has also developed a new chewable form of Lipitor, including a pediatric-appropriate 5 mg dose, which is part of this submission.

4Vote!

Pfizer Submits New Pediatric Data For Lipitor® (Atorvastatin) To The European Medicines Agency (EMEA)

NEW YORK--(BUSINESS WIRE)--Pfizer Inc (NYSE:PFE) announced it has submitted pediatric data for Lipitor® (atorvastatin) to the European Medicines Agency (EMEA). Pfizer has also developed a new chewable form of Lipitor, including a pediatric-appropriate 5 mg dose, which is part of this submission. Approximately one in 500 people suffer from an inherited disorder, called Familial Hypercholesterolemia...

3Vote!

LiquidStockReport.com on Lucrative Market Opportunities - GELV

( EMAILWIRE.COM , November 13, 2009 ) Del Mar, CA Green Energy Live has astutely chosen to initially target its focus on manure to energy conversion systems for farmers where it can have the largest and quickest impact. Technology that enables livestock operators to generate electricity while disposing of animal waste will be hugely valuable to the agriculture industry. GELV's solutions will allow...

5Vote!

Governor-Elect Christie Announces Chairs of Transition Task Force on Budget and Taxes

Trenton, NJ – Governor-Elect Chris Christie today named two budget and fiscal experts to chair a special Transition Task Force on Budget and Taxes and asked them to get to work immediately on developing recommendations to help address New Jersey’s fiscal challenges. The Governor-Elect named Richard H. Bagger of Westfield, an executive at Pfizer Inc and a former Chairman of the Assembly...

3Vote!

Report Shows Pfizer's Hand In Neurontin Studies

A study of internal company documents suggests Pfizer Inc altered or omitted unfavorable study findings to expand its epilepsy drug Neurontin's market....

3Vote!

Pfizer Moving Fast with Wyeth Integration – Software Analysis Can Help Make this Happen

Going back in time I can remember the acquisition of Warner Lambert, which since has been purchased by Johnson and Johnson as I used to do business with Pfizer and yet it seemed like it took forever. Not only in pharma, but I think today all mergers and acquisitions are moving at rocket speeds, first of all simply due to the economy. Second of all, it is possible today with business intelligence software...

3Vote!

StockSource.us Reports on Self Contained Solutions from MNDP

( EMAILWIRE.COM , November 09, 2009 ) Del Mar, CA - AirStar International, a subsidiary of Mundus, Group, Inc., has been an innovator and world leader in the design, engineering, development, production and sales in Unmanned Air Vehicles and Remote Controlled Vertical Take Off and Landing technology for the past 20 years. They now announce the formation of their new division, AirStar Foto Worx which...

6Vote!

Monsanto to Purchase Chesterfield Village Research Center From Pfizer

ST. LOUIS, Nov. 9, 2009 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON) and Pfizer Inc (NYSE: PFE) today announced that they have entered into an agreement for Monsanto to acquire Pfizer's Chesterfield Village Research Center located in Chesterfield, Mo. Under the terms of the agreement, Monsanto will acquire the property from Pfizer for $435 million to be paid over time, and Pfizer will continue...

3Vote!

StockSource.us Reports on Continued Demand for Cost Effective Technology - MNDP

( EMAILWIRE.COM , November 06, 2009 ) Del Mar, CA - With AirStar International having recently committed to a working relationship with Aero Deportes, which will use AirStar technology to assist with the filming of upcoming movies and to capture aerial footage of marathons and soccer matches within Ecuador, the continuing demand for cost effective technology is evident. AirStar, a subsidiary of Mundus,...

3Vote!

Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer's Disease

Pfizer Inc (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) today announced the initiation of CONTACT and CONSTELLATION, two Phase 3 trials of the investigational drug dimebon (latrepirdine)* in patients with moderate-to-severe Alzheimer's disease (AD).

3Vote!

WallstreetStockReview.com on Providing to a Diverse Market MNDP

( EMAILWIRE.COM , November 04, 2009 ) Del Mar, CA Mundus Group, Inc. have only begun to tap into their vast growth potential and the development of their professional and commercial demand base with its announcement of new division AirStar Foto Worx. AirStar Foto Worx will continue use of Unmanned Aircraft Vehicles (UAV) for professional aerial photography sales and service. This division will have...

4Vote!

Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer’s Disease

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Pfizer Inc (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) today announced the initiation of CONTACT and CONSTELLATION, two Phase 3 trials of the investigational drug dimebon (latrepirdine)* in patients with moderate-to-severe Alzheimer’s disease (AD). The CONTACT study will assess as primary endpoints the potential benefits of adding dimebon to...

6Vote!

Pfizer Declares a 16-Cent Fourth-Quarter 2009 Dividend

NEW YORK--(BUSINESS WIRE)--The board of directors of Pfizer Inc (NYSE: PFE) today declared a 16-cent fourth-quarter 2009 dividend on the company’s common stock, payable December 1, 2009, to shareholders of record at the close of business on November 6, 2009. The fourth-quarter 2009 cash dividend will be the 284th consecutive quarterly dividend paid by Pfizer.